Benzinga | Nov 5, 2020 12:16PM EST

Canaccord Genuity Maintains Buy on Repro-Med Systems, Lowers Price Target to $10

Canaccord Genuity maintains Repro-Med Systems (NASDAQ:KRMD) with a Buy and lowers the price target from $13 to $10.